Monteleone P et al. |
Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. |
2005 |
Neuropsychopharmacology |
pmid:15841111
|
Leweke FM et al. |
Elevated endogenous cannabinoids in schizophrenia. |
1999 |
Neuroreport |
pmid:10501554
|
Beltramo M and Piomelli D |
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. |
2000 |
Neuroreport |
pmid:10817598
|
Harris J et al. |
Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo. |
2000 |
Neuroreport |
pmid:10976969
|
Szöke E et al. |
Interacting effects of capsaicin and anandamide on intracellular calcium in sensory neurones. |
2000 |
Neuroreport |
pmid:10884049
|
Molina-Holgado F et al. |
Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes. |
1997 |
Neuroreport |
pmid:9223079
|
Cottone E et al. |
Goldfish CB1 mRNA expression is affected by fasting and anandamide administration. |
2009 |
Neuroreport |
pmid:19293731
|
Sparling PB et al. |
Exercise activates the endocannabinoid system. |
2003 |
Neuroreport |
pmid:14625449
|
Murillo-RodrÃguez E et al. |
Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. |
2001 |
Neuroreport |
pmid:11447321
|
Shinohara Y et al. |
Cannabinoid in the nucleus accumbens enhances the intake of palatable solution. |
2009 |
Neuroreport |
pmid:19734811
|
Ishii I and Chun J |
Anandamide-induced neuroblastoma cell rounding via the CB1 cannabinoid receptors. |
2002 |
Neuroreport |
pmid:11973452
|
Rubio M et al. |
Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. |
2007 |
Neurosci. Lett. |
pmid:17574742
|
Jaggar SI et al. |
The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder. |
1998 |
Neurosci. Lett. |
pmid:9774165
|
Milton NG |
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. |
2002 |
Neurosci. Lett. |
pmid:12384227
|
Abalo R et al. |
Evaluation of the effect of age on cannabinoid receptor functionality and expression in guinea-pig ileum longitudinal muscle-myenteric plexus preparations. |
2005 Jul 22-29 |
Neurosci. Lett. |
pmid:15936532
|
Raffa RB et al. |
Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice. |
1999 |
Neurosci. Lett. |
pmid:10218903
|
Mendiguren A and Pineda J |
Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices. |
2004 |
Neurosci. Lett. |
pmid:15157983
|
Sinor AD et al. |
Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. |
2000 |
Neurosci. Lett. |
pmid:10653017
|
MartÃnez-González D et al. |
Oleamide and anandamide effects on food intake and sexual behavior of rats. |
2004 |
Neurosci. Lett. |
pmid:15193744
|
Abalo R et al. |
Postnatal maturation of the gastrointestinal tract: a functional and immunohistochemical study in the guinea-pig ileum at weaning. |
2009 |
Neurosci. Lett. |
pmid:19819299
|
Németh J et al. |
Concentration-dependent dual effect of anandamide on sensory neuropeptide release from isolated rat tracheae. |
2003 |
Neurosci. Lett. |
pmid:12499047
|
Rueda-Orozco PE et al. |
Intrahippocampal administration of anandamide increases REM sleep. |
2010 |
Neurosci. Lett. |
pmid:20188142
|
Pamplona FA et al. |
Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice. |
2010 |
Neurosci. Lett. |
pmid:20036315
|
Luo C et al. |
Anandamide inhibits excitatory transmission to rat substantia gelatinosa neurones in a manner different from that of capsaicin. |
2002 |
Neurosci. Lett. |
pmid:11872246
|
Doroshenko P and Renaud LP |
Acid-sensitive TASK-like K+ conductances contribute to resting membrane potential and to orexin-induced membrane depolarization in rat thalamic paraventricular nucleus neurons. |
2009 |
Neuroscience |
pmid:19135504
|
Mahmud A et al. |
Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons. |
2009 |
Neuroscience |
pmid:19463903
|
Dowie MJ et al. |
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. |
2009 |
Neuroscience |
pmid:19524019
|
Straiker A and Mackie K |
Cannabinoid signaling in inhibitory autaptic hippocampal neurons. |
2009 |
Neuroscience |
pmid:19501632
|
De Petrocellis L et al. |
Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. |
1999 |
Neuroscience |
pmid:10392859
|
Musella A et al. |
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. |
2010 |
Neuroscience |
pmid:20219639
|
Tree K et al. |
Anandamide centrally depresses the respiratory rhythm generator of neonatal mice. |
2010 |
Neuroscience |
pmid:20800658
|
Szoke E et al. |
Neonatal anandamide treatment results in prolonged mitochondrial damage in the vanilloid receptor type 1-immunoreactive B-type neurons of the rat trigeminal ganglion. |
2002 |
Neuroscience |
pmid:12435419
|
Veeraraghavan P et al. |
A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro. |
2016 |
Neuroscience |
pmid:27450568
|
Palkovits M et al. |
Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. |
2008 |
Neuroscience |
pmid:18343585
|
Yang W et al. |
Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells. |
2016 |
Neuroscience |
pmid:26621126
|
Schmidt W et al. |
Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia. |
2012 |
Neuroscience |
pmid:23069763
|
Sticht MA et al. |
Intra-visceral insular cortex 2-arachidonoylglycerol, but not N-arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats. |
2015 |
Neuroscience |
pmid:25499318
|
Palmer JA et al. |
Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse. |
2008 |
Neuroscience |
pmid:18541380
|
Murillo-RodrÃguez E et al. |
The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. |
2008 |
Neuroscience |
pmid:18822353
|
Singh Tahim A et al. |
Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons. |
2005 |
Neuroscience |
pmid:16198486
|
Muthian S et al. |
Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. |
2004 |
Neuroscience |
pmid:15541895
|
de Oliveira Alvares L et al. |
Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction. |
2008 |
Neuroscience |
pmid:18554811
|
Smaga I et al. |
Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures. |
2014 |
Neurotox Res |
pmid:24652522
|
Smaga I et al. |
Changes in the Brain Endocannabinoid System in Rat Models of Depression. |
2017 |
Neurotox Res |
pmid:28247204
|
Liu J and Pope C |
The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats. |
2015 |
Neurotoxicology |
pmid:25447325
|
Harvey BS et al. |
Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro. |
2012 |
Neurotoxicology |
pmid:22233683
|
Carr RL et al. |
Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development. |
2017 |
Neurotoxicology |
pmid:26642910
|
Carr RL et al. |
Low level chlorpyrifos exposure increases anandamide accumulation in juvenile rat brain in the absence of brain cholinesterase inhibition. |
2014 |
Neurotoxicology |
pmid:24373905
|
Gasperi V et al. |
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. |
2005 |
Neurotoxicology |
pmid:16154199
|
Deutsch DG and Makriyannis A |
Inhibitors of anandamide breakdown. |
1997 |
NIDA Res. Monogr. |
pmid:9260184
|
Kudo R and Hatake K |
[Effect of ethanol on anandamide-induced sensory nerve dependent vasorelaxation]. |
2006 |
Nihon Arukoru Yakubutsu Igakkai Zasshi |
pmid:17313058
|
Hayase T et al. |
Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity. |
2001 |
Nihon Arukoru Yakubutsu Igakkai Zasshi |
pmid:11828716
|
Kudo R and Hatake K |
[Effect of ethanol on anandamide-induced sensory nerve dependent vasorelaxation (the second report)]. |
2008 |
Nihon Arukoru Yakubutsu Igakkai Zasshi |
pmid:18646646
|
Yamaguchi Y et al. |
[Surgical stress]. |
2005 |
Nihon Geka Gakkai Zasshi |
pmid:16045189
|
Kamei J et al. |
[Sensitization of cough sensitivity through activation of C-and/or Adelta fibers]. |
2008 |
Nippon Yakurigaku Zasshi |
pmid:18552444
|
Romero TR et al. |
The neuronal NO synthase participation in the peripheral antinociception mechanism induced by several analgesic drugs. |
2011 |
Nitric Oxide |
pmid:21875681
|
Haas MJ et al. |
Inhibition of apolipoprotein A-I gene expression by obesity-associated endocannabinoids. |
2012 |
Obesity (Silver Spring) |
pmid:22016100
|
Gonthier MP et al. |
Identification of endocannabinoids and related compounds in human fat cells. |
2007 |
Obesity (Silver Spring) |
pmid:17426318
|
Engeli S et al. |
Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects. |
2014 |
Obesity (Silver Spring) |
pmid:24616451
|
Starowicz KM et al. |
Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. |
2008 |
Obesity (Silver Spring) |
pmid:18239598
|
Karaliota S et al. |
Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation. |
2009 |
Obesity (Silver Spring) |
pmid:19543211
|
Zelber-Sagi S et al. |
Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease. |
2017 |
Obesity (Silver Spring) |
pmid:27863097
|
Abdulnour J et al. |
Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study. |
2014 |
Obesity (Silver Spring) |
pmid:23616305
|
Engeli S et al. |
Peripheral endocannabinoid system activity in patients treated with sibutramine. |
2008 |
Obesity (Silver Spring) |
pmid:18356837
|
Alvheim AR et al. |
Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. |
2012 |
Obesity (Silver Spring) |
pmid:22334255
|
Tong S et al. |
Diagnostic accuracy of maternal serum macrophage inhibitory cytokine-1 and pregnancy-associated plasma protein-A at 6-10 weeks of gestation to predict miscarriage. |
2012 |
Obstet Gynecol |
pmid:22525911
|
Bernabò N et al. |
Systems biology analysis of the endocannabinoid system reveals a scale-free network with distinct roles for anandamide and 2-arachidonoylglycerol. |
2013 |
OMICS |
pmid:24117401
|
Orellana-Serradell O et al. |
Proapoptotic effect of endocannabinoids in prostate cancer cells. |
2015 |
Oncol. Rep. |
pmid:25606819
|
Scholl A et al. |
Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2. |
2016 |
Oncotarget |
pmid:27556861
|
Ravi J et al. |
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway. |
2014 |
Oncotarget |
pmid:24811863
|
Palkovits M |
[The brain and the pain: neurotransmitters and neuronal pathways of pain perception and response]. |
2000 |
Orv Hetil |
pmid:11184247
|
Jia J et al. |
Anandamide protects HT22 cells exposed to hydrogen peroxide by inhibiting CB1 receptor-mediated type 2 NADPH oxidase. |
2014 |
Oxid Med Cell Longev |
pmid:25136404
|
Farquhar-Smith WP et al. |
Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. |
2002 |
Pain |
pmid:12031775
|
Horvath G et al. |
The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level. |
2008 |
Pain |
pmid:17533116
|
Lichtman AH et al. |
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. |
2004 |
Pain |
pmid:15157693
|
Guindon J et al. |
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain. |
2006 |
Pain |
pmid:16480822
|
Jaggar SI et al. |
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. |
1998 |
Pain |
pmid:9696473
|
Butler RK et al. |
Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates. |
2008 |
Pain |
pmid:19004548
|
Richardson JD et al. |
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. |
1998 |
Pain |
pmid:9539680
|
Kenessey I et al. |
Revisiting CB1 receptor as drug target in human melanoma. |
2012 |
Pathol. Oncol. Res. |
pmid:22447182
|
Krishtal O et al. |
The agonists for nociceptors are ubiquitous, but the modulators are specific: P2X receptors in the sensory neurons are modulated by cannabinoids. |
2006 |
Pflugers Arch. |
pmid:16741755
|
Laine K et al. |
Effects of topical anandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbits. |
2001 |
Pharm. Res. |
pmid:11451037
|
Pate DW et al. |
Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits. |
1997 |
Pharm. Res. |
pmid:9453062
|
Sadhasivam S et al. |
Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects. |
2015 |
Pharmacogenomics J. |
pmid:25558980
|
Fowler CJ et al. |
The endocannabinoid signaling system: pharmacological and therapeutic aspects. |
2005 |
Pharmacol. Biochem. Behav. |
pmid:15935456
|
Smith FL et al. |
Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9610941
|
Wiley JL |
Cannabis: discrimination of "internal bliss"? |
1999 |
Pharmacol. Biochem. Behav. |
pmid:10515300
|
Romero J et al. |
Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. |
1995 |
Pharmacol. Biochem. Behav. |
pmid:7675852
|
Wiley JL and Burston JJ |
Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in rats. |
2010 |
Pharmacol. Biochem. Behav. |
pmid:19941884
|
Herrera-SolÃs A et al. |
Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats. |
2010 |
Pharmacol. Biochem. Behav. |
pmid:20056119
|
Rawls SM et al. |
Role of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats. |
2006 |
Pharmacol. Biochem. Behav. |
pmid:16647109
|
Crawley JN et al. |
Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. |
1993 |
Pharmacol. Biochem. Behav. |
pmid:7906042
|
Wiley JL et al. |
Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. |
1997 |
Pharmacol. Biochem. Behav. |
pmid:9408225
|
Wenger T et al. |
The effects of prenatally administered endogenous cannabinoid on rat offspring. |
1997 |
Pharmacol. Biochem. Behav. |
pmid:9300616
|
Reyes-Cabello C et al. |
Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration. |
2012 |
Pharmacol. Biochem. Behav. |
pmid:22133635
|
Tuboly G et al. |
The antinociceptive interaction of anandamide and adenosine at the spinal level. |
2009 |
Pharmacol. Biochem. Behav. |
pmid:18760296
|
Sulcova E et al. |
Biphasic effects of anandamide. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9476980
|
De Petrocellis L et al. |
N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity. |
2011 |
Pharmacol. Res. |
pmid:21215315
|
Fowler CJ and Ghafouri N |
Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? |
2008 |
Pharmacol. Res. |
pmid:18675915
|
Khasabova IA et al. |
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain. |
2011 |
Pharmacol. Res. |
pmid:21440630
|